 |
Sucralfate suspension |
|---|---|
| Trade Name | |
| Orphan Indication | Oral complications of chemotherapy in bone marrow transplant patients |
| USA Market Approval | USA |
| USA Designation Date | 1990-03-12 00:00:00 |
| Sponsor | Darby Pharmaceuticals, Inc.;100 Banks Avenue;Rockville Centre, New York, 11570 |
